Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer. File DM, Pascual T, Deal AM, Wheless A, et al. Breast Cancer Res Treat 2022 Aug 25. pii: 10.1007/s10549-022-06700.

Read + Share

Amedeo Smart

Independent Medical Education

File DM, Pascual T, Deal AM, Wheless A, et al. Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer. Breast Cancer Res Treat 2022 Aug 25. pii: 10.1007/s10549-022-06700.
PMID: 36008651